| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $576.3M | +34.5% |
| Cost of Revenue | $211.9M | +24.2% |
| Gross Profit | $364.4M | +41.3% |
| R&D Expense | $143.9M | +24.4% |
| SG&A Expense | $165.2M | +61.0% |
| Operating Income | -$26.2M | -134.4% |
| Interest Expense | $8.4M | +124.3% |
| Pre-tax Income | -$24.4M | -34.1% |
| Income Tax | -$124K |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $140.8M | -91.8% |
| Short-term Investments | $723.5M | — |
| Accounts Receivable | $53.8M | +35.9% |
| Current Assets | $946.6M | -46.5% |
| Total Assets | $1.82B | -13.6% |
| Current Liabilities | $164.3M | +182.1% |
| Long-term Debt | $1.47B | +0.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $195.2M | +46.6% |
| Capital Expenditures | $106.4M | +9.6% |
| Investing Cash Flow | -$1.15B | -910.7% |
| Financing Cash Flow | -$610.4M | -138.3% |
| Free Cash Flow | $88.8M | +146.3% |
| -109.5% |
| Net Income | -$24.3M | -24.5% |
| EPS (Basic) | -$0.24 | -14.3% |
| EPS (Diluted) | -$0.24 | -14.3% |
| Total Liabilities |
| $1.76B |
| +15.9% |
| Stockholders' Equity | $51.1M | -91.2% |